Startup tests resistance to HIV drugs

June 8, 2014 - Boston Herald

by Marie Szaniszlo

A simple, fast, affordable test developed by a Boston-based MassChallenge finalist is able to determine which drugs HIV is resistant to, saving money and lives.

Using a technology called Pan Degenerate Amplification and Adaptation, Aldatu Biosciences allows doctors to match patients with drugs the HIV won't be resistant to, based on the genetics of the virus.

"If resistance is present, switching people to effective drugs improves quality of life and saves money by reducing the risk of new infections," Aldatu CEO David Raiser said. "If resistance is not present, money is saved by not switching patients to more expensive drugs unnecessarily. There are clear economic and public health benefits to performing the test, regardless of the result." Continue reading...

like0

Do you get our newsletter?

admin's picture

Sign up for our monthly Newsletter and get the latest info in your inbox.

seventh name
Wed, 7/26/2017 - 9:42am
Wed, 7/26/2017 - 7:00am

Women-specific Care: Sexual and Reproductive Health Continuum and HIV; Mental Health and HIV was the final in our eight-week webinar series that offers women living with HIV capacity building and training on HIV disease and treatment advocacy.

Get information on options for reducing the chances of spreading HIV while trying to get pregnant and resources for safer conception.

Look here to find information and support for health issues, violence, stigma and discrimination, legal barriers, transgender youth, and more.

admin's picture

Join our community

Connect to our support community and share experiences with other women living with HIV.

Join now >

admin's picture

You Can Help!

Together, we can change the course of the HIV epidemic…one woman at a time!

Please donate now!>